AA
BDSX icon

ACT Advisors’s Biodesix BDSX Stock Holding History

ACT Advisors’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-558
Closed -$17.1K – 60
2024
Q4 		$17.1K Buy
+558
New +$16.4K 0.01% 52

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACT Advisors's BDSX Position: Q1 2025 in Review

ACT Advisors sold out of Biodesix (BDSX) in Q1 2025, closing a stake of 558 shares — an estimated $17.1K sold.

ACT Advisors first reported a position in BDSX in Q4 2024 and held it in 1 quarter. The position peaked at $17.1K in Q4 2024. 59 funds tracked by Wall St. Rank hold BDSX as of Q1 2025.

  • ACT Advisors reported no remaining Biodesix position as of Q1 2025 after selling out during the quarter.
  • ACT Advisors sold 558 Biodesix shares in Q1 2025, an estimated $17.1K.
  • ACT Advisors first reported a position in Biodesix in Q4 2024 and held it in 1 quarter.
  • ACT Advisors's Biodesix position peaked at $17.1K in Q4 2024.
  • 59 funds tracked by Wall St. Rank held Biodesix as of Q1 2025.

Based on ACT Advisors's 13F filing for Q1 2025, filed 10 Apr 2025.